Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany. Lancet Psychiatry. 2026 13(2):91-93. Epub 2025 Sep 18.
Knabbe J, Sartorius A. Just a Caffeine-Blocker? Questioning New Proposed Core Mechanisms of ECT. Brain Stimul. 2026 Apr 25. [Epub ahead of print] :103108.
Mertens L, Koslowski M, Betzler F, Brand M, Evens R, Kärtner L, Jungaberle A, Jungaberle H, Majic T, Schmitz C, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Kirchen N, Kulakova E, Kunz L, Meijer A, Rohrmoser B, Wellek S, Berger M, Gründer G. Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial. JAMA Psychiatry. 2026 Mar 18. [Epub ahead of print]
Volkmer S, Kubera KM, Fritze S, Brandt G, Akkoc Altinok DC, Daub J, Kukovic J, Böttcher KT, Berhe O, Lin Y, Tost H, Marquand AF, Meyer-Lindenberg A, Schwarz E, Hirjak D. Normative age-related structural brain deviations underlying psychopathology, cognitive impairment and neurological soft signs in schizophrenia spectrum disorders. Transl Psychiatry. 2026 16(1):197. Epub 2026 Mar 20.
Zilles-Wegner D, Wasserman D, Schulze TG, Pogarell O, Miskimen T, Rapaport MH, Summergrad P, Fiorillo A, Arango C, Global Expert Taskforce on ECT Global Expert Taskforce on ECT, Sartorius A. Joint statement by the World Psychiatric Association, the American Psychiatric Association, the European Psychiatric Association, and the Global Expert Task Force on ECT on the portrayal of electroconvulsive therapy in the WHO Guidance on Mental Health Policy and Strategic Action Plans. Lancet Psychiatry. 2026 13(5):441-444. Epub 2026 Mar 31.